Gil, Carmen

	Rights	Preview	Issue Date	Title	Author(s)	Type
1	closedAccess		2012	5-imino-1,2,4-thiadiazoles: first small molecules as substrate competitive inhibitors of glycogen synthase kinase 3	Palomo, Valle  ; Pérez, Daniel I.; Pérez, Concepción; Morales-García, José A. ; Soteras, Ignacio ; Alonso-Gil, Sandra ; Encinas, Arantxa; Castro, Ana ; Campillo, Nuria E.  ; Pérez Castillo, Ana ; Gil, Carmen  ; Martínez, Ana	artículo
2	closedAccess		2006	Advances in the synthesis and recent therapeutic applications of 1,2,4-thiadiazole heterocycles	Castro, Ana ; Castaño, Tania; Encinas, Arantxa; Porcal, Williams; Gil, Carmen	artículo
3	closedAccess		2012	An Introduction to Solid-Phase Palladium Chemistry	Gil, Carmen	artículo
4	closedAccess		2001	Anti-HIV-1 activity of benzothiadiazine dioxide	Martínez, Ana  ; Gil, Carmen  ; Castro, Ana ; Pérez, Concepción; Witvrouw, M.; Pannecouque, C.; Balzarini, Jan; De Clercq, Erik	artículo
5	closedAccess		2009	Anti-trypanosomatid benzofuroxans and deoxygenated analogues: Synthesis using polymer-supported triphenylphosphine, biological evaluation and mechanism of action studies	Castro, Diego; Boiani, Lucía; Benitez, Diego; Hernández, Paola; Merlino, Alicia; Gil, Carmen  ; Olea-Azar, Claudio A.; González, Mercedes; Cerecetto, Hugo; Porcal, Williams	artículo
6	closedAccess		2000	Benzothiadiazine dioxide dibenzyl derivatives as potent human cytomegalovirus inhibitors: Synthesis and comparative molecular field analysis	Martínez, Ana  ; Gil, Carmen  ; Abasolo, M. Inés; Castro, Ana ; Bruno, Ana M.; Pérez, Concepción; Prieto, Columbiana; Otero, J.	artículo
7	openAccess		2003	Benzothiadiazine dioxide human cytomegalovirus inhibitors: Synthesis and antiviral evaluation of main heterocycle modified derivatives	Martínez, Ana  ; Gil, Carmen  ; Castro, Ana ; Bruno, Ana M.; Pérez, Concepción; Prieto, Columbiana; Otero, Joaquín	artículo
8	closedAccess		2003	Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. Study of structural requirements for biological activity	Martínez, Ana  ; Gil, Carmen  ; Castro, Ana ; Pérez, Concepción; Prieto, C. ; Otero, Joaquín	artículo
9	openAccess		11-Dec-2019	Benzothiazole-based LRRK2 inhibitors as Wnt enhancers and promoters of oligodendrocytic fate	Zaldívar-Díez, Josefa; Li, Lingling; García, Ana M. ; Zhao, Wenning; Medina-Menendez, Cristina; Haggarty, Stephen J.; Gil, Carmen  ; Morales, Aixa V. ; Martínez, Ana	artículo
10	closedAccess		2000	Benzyl derivatives of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides: First phosphodiesterase 7 inhibitors	Martínez, Ana  ; Castro, Ana ; Gil, Carmen  ; Miralpeix, Montserrat; Segarra, Víctor; Doménech, Teresa; Beleta, Jorge; Palacios, José M.; Ryder, Hamish; Miró, Xavier; Bonet-Costa, Carles ; Casacuberta, Josep M. ; Azorín, Ferran  ; Piña, Benjamín  ; Puigdomènech, Pere	artículo
11	openAccess		30-Aug-2017	Biological and pharmacological characterization of benzothiazole-based CK-1δ inhibitors in models of Parkinson’s disease	Morales-García, José A. ; Salado, Irene G. ; Sanz-SanCristóbal, Marina ; Gil, Carmen  ; Pérez Castillo, Ana ; Martínez, Ana  ; Pérez, Daniel I.	artículo
12	closedAccess		2015	Biology-oriented development of novel lipophilic antioxidants with neuroprotective activity	Silva, T.; Bravo, J.; Summavielle, T.; Remião, Fernando; Perez, C.; Gil, Carmen  ; Martínez, Ana  ; Borges, Fernanda	artículo
13	openAccess		4-Oct-2014	cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases	Martínez, Ana  ; Gil, Carmen	artículo
14	closedAccess		2008	CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application example	Castro, Ana ; Jerez, María José; Gil, Carmen  ; Calderón, Félix ; Doménech, Teresa; Nueda, Arsenio; Martínez, Ana	artículo
15	closedAccess		2004	CODES/neural network model: A useful tool for in silico prediction of oral absorption and blood-brain barrier permeability of structurally diverse drugs	Dorronsoro Díaz, Isabel; Chana, A.; Abasolo, Ibane; Castro, Ana ; Gil, Carmen  ; Stud Schlüter, Manfred; Martinez, A.	artículo
16	closedAccess		Dec-2020	Cognitive enhancement, TAU phosphorylation reduction, and neuronal protection by the treatment of an LRRK2 inhibitor in a tauopathy mouse model	Castro-Sánchez, Sara; Zaldívar-Díez, Josefa; Luengo, Enrique; López, Manuela G.; Gil, Carmen  ; Martínez, Ana  ; Lastres-Becker,Isabel	artículo
17	closedAccess		2001	CoMFA of benzyl derivatives of 2,1,3-benzo and benzothieno[3,2-a]thiadiazine 2,2-dioxides: Clues for the design of phosphodiesterase 7 inhibitors	Castro, Ana ; Abasolo, M. Inés; Gil, Carmen  ; Segarra, Victor; Martínez, Ana	artículo
18	closedAccess		2013	Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis	González-García, C.; Bravo, B.; Ballester, A.; Gõmez-Pérez, R.; Eguiluz, César; Redondo, Miriam ; Martínez, Ana  ; Gil, Carmen  ; Ballester, S.	artículo
19	embargoedAccess		8-Jun-2020	COVID-19: Drug targets and potential treatments	Gil, Carmen  ; Ginex, Tiziana ; Maestro, Inés; Nozal, V.; Barrado-Gil, Lucía; Cuesta-Geijo, Miguel Ángel; Urquiza, Jesús; Ramírez, David; Alonso, Covadonga; Campillo, Nuria E.  ; Martínez, Ana	artículo
20	closedAccess		2014	Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: Two relevant therapeutic targets for neurological disorders	Morales-García, José A. ; Palomo, Valle  ; Redondo, Miriam ; Alonso-Gil, Sandra ; Gil, Carmen  ; Martínez, Ana  ; Pérez Castillo, Ana	artículo